glycophorin-A O-glycosylated 90 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-23 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G01614ZM. Example: UniProtKB:P02724-1, Thr-23, MOD:00005~GNO:G01614ZM.


glycophorin-A O-glycosylated 13 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-30 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G01614ZM. Example: UniProtKB:P02724-1, Ser-30, MOD:00002~GNO:G01614ZM.


glycophorin-A O-glycosylated 32 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-32 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G94217FB. Example: UniProtKB:P02724-1, Ser-32, MOD:00002~GNO:G94217FB.


name: glycophorin-A O-glycosylated 166 (human)

description: A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-69 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G00031MO. Example: UniProtKB:P02724-1, Thr-69, MOD:00005~GNO:G00031MO.


glycophorin-A O-glycosylated 55 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-41 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G94435QH. Example: UniProtKB:P02724-1, Ser-41, MOD:00002~GNO:G94435QH.


glycophorin-A O-glycosylated 45 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-41 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G00031MO. Example: UniProtKB:P02724-1, Ser-41, MOD:00002~GNO:G00031MO.


name: glycophorin-A O-glycosylated 164 (human)

description: A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-56 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G94217FB. Example: UniProtKB:P02724-1, Thr-56, MOD:00005~GNO:G94217FB.


name: glycophorin-A O-glycosylated 109 (human)

description: A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-29 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G94217FB. Example: UniProtKB:P02724-1, Thr-29, MOD:00005~GNO:G94217FB.


name: glycophorin-A O-glycosylated 119 (human)

description: A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-31 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02724-1, Thr-31, MOD:00005~GNO:G65562ZE.


name: glycophorin-A O-glycosylated 146 (human)

description: A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-52 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G16370GQ. Example: UniProtKB:P02724-1, Thr-52, MOD:00005~GNO:G16370GQ.


glycophorin-A O-glycosylated 81 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-22 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G33350UC. Example: UniProtKB:P02724-1, Thr-22, MOD:00005~GNO:G33350UC.


glycophorin-A O-glycosylated 39 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-38 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G47180UC. Example: UniProtKB:P02724-1, Ser-38, MOD:00002~GNO:G47180UC.


glycophorin-A O-glycosylated 30 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-32 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G56682BC. Example: UniProtKB:P02724-1, Ser-32, MOD:00002~GNO:G56682BC.


glycophorin-A O-glycosylated 95 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-23 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G56245IE. Example: UniProtKB:P02724-1, Thr-23, MOD:00005~GNO:G56245IE.


glycophorin-A O-glycosylated 42 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-38 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G65562ZE. Example: UniProtKB:P02724-1, Ser-38, MOD:00002~GNO:G65562ZE.


glycophorin-A O-glycosylated 80 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Thr-22 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G16370GQ. Example: UniProtKB:P02724-1, Thr-22, MOD:00005~GNO:G16370GQ.


glycophorin-A O-glycosylated 7 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-21 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G56245IE. Example: UniProtKB:P02724-1, Ser-21, MOD:00002~GNO:G56245IE.


glycophorin-A O-glycosylated 60 (human)

A glycophorin-A (human) that has been O-glycosylated at the residue equivalent to Ser-63 of the amino acid sequence represented by UniProtKB:P02724-1, in which the glycan structure is represented by GlyTouCan:G42797SX. Example: UniProtKB:P02724-1, Ser-63, MOD:00002~GNO:G42797SX.


name: U3 small nucleolar RNA-associated protein 18 homolog methylated 1 (human)

description: A U3 small nucleolar RNA-associated protein 18 homolog (human) that has been methylated on the residue at the position equivalent to Cys-507 of the amino acid sequence represented by UniProtKB:Q9Y5J1. UniProtKB:Q9Y5J1, Cys-507, MOD:00660.


afadin methylated 1 (human)

An afadin (human) that has been methylated on the residue at the position equivalent to Cys-960 of the amino acid sequence represented by UniProtKB:P55196-4. Example: UniProtKB:P55196-4, Cys-960, MOD:00660.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase

description: A protein that is a translation product of the human ALG6 gene or a 1:1 ortholog thereof.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase sequence variant A333V (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human) that has a Val residue at the position equivalent to Ala-333 of the amino acid sequence represented by UniProtKB:Q9Y672. UniProtKB:Q9Y672, Ala-333, CHEBI:30015.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase methylated 1 (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human) that has been methylated on the residue at the position equivalent to Cys-401 of the amino acid sequence represented by UniProtKB:Q9Y672. UniProtKB:Q9Y672, Cys-401, MOD:00660.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase sequence variant 1 (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human) that has a Val residue at the position equivalent to Ala-333 and a Pro residue at the position equivalent to Ser-478 of the amino acid sequence represented by UniProtKB:Q9Y672. UniProtKB:Q9Y672, Ala-333, CHEBI:30015|Ser-478, CHEBI:50342.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform 1 (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform 1 that is encoded in the genome of human.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase methylated 2 (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human) that has been methylated on the residue at the position equivalent to Cys-431 of the amino acid sequence represented by UniProtKB:Q9Y672. UniProtKB:Q9Y672, Cys-431, MOD:00660.


name: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase cysteinylated 1 (human)

description: A dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (human) that has been cysteinylated on the residue at the position equivalent to Cys-401 of the amino acid sequence represented by UniProtKB:Q9Y672. UniProtKB:Q9Y672, Cys-401, MOD:00765.


A 2,3-diacyl-sn-glycerol in which both acyl groups are specified as linolenoyl.


name: macrophage mannose receptor 1 O-glycosylated 1 (human)

description: A macrophage mannose receptor 1 (human) that has been O-glycosylated at the residue equivalent to Thr-1093 of the amino acid sequence represented by UniProtKB:P22897-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P22897-1, Thr-1093, MOD:00005~GNO:G29068FM.


otospiralin isoform 1 (human)

An otospiralin isoform 1 that is encoded in the genome of human.


name: zinc finger protein 85 isoform h3 (human)

description: A zinc finger protein 85 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q03923-3.


name: digestive duplication cyst of the tongue

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Digestive duplication cyst of the tongue is an extremely rare otorhinolaryngological malformation which occurs during early embryogenesis and is characterized by a single, and on occasion multiple, cystic lesion that is most frequently located in the anterior portion of the tongue, either deeply embedded within it or superficially on it. Depending mostly on size and location of the cyst, patients could be asymptomatic or could present a wide array of symptoms, such as varying degrees of respiratory and feeding difficulties, lingual swelling and protrusion, dysphagia, and more rarely, recurrent bleeding or brownish discharge from a lingual sinus.


Adenosquamous cell lung cancer stage II

description: Stage II includes: IIA (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0) and IIB (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)


name: Lung Adenosquamous Carcinoma by AJCC v7 Stage

description: A term that refers to the staging of adenosquamous lung carcinoma, following the rules of the TNM AJCC v7 classification system.


name: Adenosquamous cell lung cancer stage III

description: Stage III includes: IIIA (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0) and IIIB (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)


Adenosquamous cell lung cancer stage I

description: Stage I includes: IA: (T1a, N0, M0); (T1b, N0, M0) and IB: (T2a, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less n greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


Adenosquamous cell lung cancer stage IV

description: Stage IV includes: (Any T, Any N, M1a); (Any T, Any N, M1b).  M1a: Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion.  M1b: Distant metastasis. (AJCC 7th ed.)


name: Stage IA Lung Adenosquamous Carcinoma AJCC v7

description: Stage IA includes: (T1a, N0, M0); (T1b, N0, M0).  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


name: Stage 0 Lung Adenosquamous Carcinoma AJCC v6 and v7

description: Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


name: Stage IIB Lung Adenosquamous Carcinoma AJCC v7

description: Stage IIB includes: (T2b, N1, M0); (T3, N0, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T3: Lung cancer with a tumor size more than 7 cm or one that directly invades any of the following: parietal pleural (PL3) chest wall (including superior sulcus tumors), diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium; or tumor in the main bronchus (less than 2 cm distal to the carina but without involvement of the carina); or associated atelectasis or obstructive pneumonitis of the entire lung or separate tumor nodule(s) in the same lobe. N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)


name: Stage IIA Lung Adenosquamous Carcinoma AJCC v7

description: Stage IIA includes: (T2b, N0, M0); (T1a, N1, M0); (T1b, N1, M0); (T2a, N1, M0).  T2b: Lung cancer with a tumor size more than 5 cm but 7 cm or less in greatest dimension.  T1a: Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a.  T1b: Lung cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus).  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph node metastasis.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension. M0: No distant metastasis. (AJCC 7th ed.)


name: Adenosquamous cell lung cancer stage IIIB

description: Stage IIIB includes: (T1a, N3, M0); (T1b, N3, M0); (T2a, N3, M0); (T2b, N3, M0); (T3, N3, M0); (T4, N2, M0); (T4, N3, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  N3: Lung cancer with metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)


name: Stage IB Lung Adenosquamous Carcinoma AJCC v7

description: Stage IB includes: T2a, N0, M0.  T2a: Lung cancer with a tumor size more than 3 cm but 5 cm or less in greatest dimension.  N0: No regional lymph metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


name: Adenosquamous cell lung cancer stage IIIA

description: Stage IIIA includes: (T1a, N2, M0); (T1b, N2, M0); (T2a, N2, M0); (T2b, N2, M0); (T3, N1, M0); (T3, N2, M0); (T4, N0, M0); (T4, N1, M0).  T4: Lung cancer with a tumor of any size that invades any of the following: mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, and separate tumor nodule(s) in a different ipsilateral lobe.  N1: Lung cancer with metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension.  N2: Lung cancer with metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes.  M0: No distant metastasis. (AJCC 7th ed.)


cyclin-A2 deaminated 2 (human)

A cyclin-A2 (human) that has been deaminated on the residue at the position equivalent to Gln-317 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Gln-317, MOD:00685.


cyclin-A2 methylated 2 (human)

A cyclin-A2 (human) that has been methylated on the residue at the position equivalent to Cys-327 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Cys-327, MOD:00660.


cyclin-A2 cysteinylated 2 (human)

A cyclin-A2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-327 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Cys-327, MOD:00765.


cyclin-A2 phosphorylated 1 (human)

A cyclin-A2 (human) that has been phosphorylated on the residue at the position equivalent to Ser-55 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Ser-55, MOD:00046.


cyclin-A2 cysteinylated 3 (human)

A cyclin-A2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-390 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Cys-390, MOD:00765.


cyclin-A2 cysteinylated 1 (human)

A cyclin-A2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-193 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Cys-193, MOD:00765.


cyclin-A2 ubiquitinated form (human)

A cyclin-A2 (human) that includes at least one ubiquitinated lysine. UniProtKB:P20248, MOD:01148.


cyclin-A2 methylated 1 (human)

A cyclin-A2 (human) that has been methylated on the residue at the position equivalent to Cys-193 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Cys-193, MOD:00660.


cyclin-A2 deaminated 1 (human)

A cyclin-A2 (human) that has been deaminated on the residue at the position equivalent to Asn-34 of the amino acid sequence represented by UniProtKB:P20248. UniProtKB:P20248, Asn-34, MOD:00684.


name: small ubiquitin-related modifier 3 isoform h1 (human)

description: A small ubiquitin-related modifier 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P55854-1.


name: Moderate Acute Respiratory Distress Syndrome

description: A form of acute respiratory distress syndrome (ARDS) that is marked by moderate hypoxemia. Based on the Berlin criteria, onset must occur within one week of a clinical insult or there must be evidence of new or worsening respiratory symptoms. Chest imaging reveals bilateral opacities consistent with pulmonary edema that are not fully explained by effusions, lobar/lung collapse, or nodules. Respiratory failure is not fully explained by heart failure or fluid overload and objective assessment, e.g. echocardiography, is required to exclude hydrostatic edema if no risk factor is present. Additionally, oxygenation as measured by a partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FIO2) is equivalent to between 100 and 200 mm Hg with positive end-expiratory pressure (PEEP) of at least 5 cm of water (Ranieri VM et al., JAMA. 2012;307(23):2526-2533).


name: leukocyte-associated immunoglobulin-like receptor 2 isoform h1 (human)

description: A leukocyte-associated immunoglobulin-like receptor 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISS4-1.


name: leukocyte-associated immunoglobulin-like receptor 2

description: A protein that is a translation product of the human LAIR2 gene or a 1:1 ortholog thereof.


name: leukocyte-associated immunoglobulin-like receptor 2 isoform h2 (human)

description: A leukocyte-associated immunoglobulin-like receptor 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISS4-2.


name: leukocyte-associated immunoglobulin-like receptor 2, signal peptide removed form (human)

description: A leukocyte-associated immunoglobulin-like receptor 2 (human) that has had the signal peptide removed. UniProtKB:Q6ISS4, 22-152.


Conjunctival Subepithelial Nevus

description: A conjunctival nevus characterized by an intrastromal proliferation of predominantly type B nevus cells.


name: nuclear mitotic apparatus protein 1 isoform h4 (human)

description: A nuclear mitotic apparatus protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q14980-4.


name: PHD and RING finger domain-containing protein 1 isoform h2 (human)

description: A PHD and RING finger domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9P1Y6-2.


name: mesoderm induction early response protein 1 isoform h8 (human)

description: A mesoderm induction early response protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N108-18.


name: filamin-binding LIM protein 1 cysteinylated 1 (human)

description: A filamin-binding LIM protein 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-266 of the amino acid sequence represented by UniProtKB:Q8WUP2-1. Example: UniProtKB:Q8WUP2-1, Cys-266, MOD:00765.


decorin isoform D (human)

A decorin isoform D that is encoded in the genome of human.


(R)-lipoamide

A lipoamide obtained by condensation of the carboxy group of (R)-lipoic acid with ammonia.


name: coiled-coil and C2 domain-containing protein 1B isoform h5 (human)

description: A coiled-coil and C2 domain-containing protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0F9-5.


name: coiled-coil and C2 domain-containing protein 1B isoform h4 (human)

description: A coiled-coil and C2 domain-containing protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0F9-4.


name: coiled-coil and C2 domain-containing protein 1B isoform h3 (human)

description: A coiled-coil and C2 domain-containing protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0F9-3.


name: coiled-coil and C2 domain-containing protein 1B isoform h2 (human)

description: A coiled-coil and C2 domain-containing protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0F9-2.


name: coiled-coil and C2 domain-containing protein 1B isoform h1 (human)

description: A coiled-coil and C2 domain-containing protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T0F9-1.


name: transcriptional activator Myb isoform h11 (human)

description: A transcriptional activator Myb (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P10242-11.


ubiquitin-conjugating enzyme E2 D3

A UBA domain-containing ubiquitin-conjugating enzyme E2 that is a translation product of the human UBE2D3 gene or a 1:1 ortholog thereof.


name: ubiquitin-conjugating enzyme E2 D3 isoform 1 (human)

description: A ubiquitin-conjugating enzyme E2 D3 isoform 1 that is encoded in the genome of human.


name: ubiquitin-conjugating enzyme E2 D3 isoform h3 (human)

description: A ubiquitin-conjugating enzyme E2 D3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P61077-3.


name: ubiquitin-conjugating enzyme E2 D3 isoform h2 (human)

description: A ubiquitin-conjugating enzyme E2 D3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P61077-2.


name: ubiquitin-conjugating enzyme E2 D3 acetylated 1 (human)

description: A ubiquitin-conjugating enzyme E2 D3 (human) that has been acetylated on the residue at the position equivalent to Lys-4 of the amino acid sequence represented by UniProtKB:P61077-1. Example: UniProtKB:P61077-1, Lys-4, MOD:00723.


name: dihydropyrimidinase-related protein 1 phosphotyrosine form (human)

description: A dihydropyrimidinase-related protein 1 (human) that includes at least one phosphorylated tyrosine. UniProtKB:Q14194, MOD:00048.


name: transitional endoplasmic reticulum ATPase methylated 1 (human)

description: A transitional endoplasmic reticulum ATPase (human) that has been methylated on the residue at the position equivalent to Cys-415 of the amino acid sequence represented by UniProtKB:P55072. UniProtKB:P55072, Cys-415, MOD:00660.


GPN-loop GTPase 3 isoform 1 (human)

A GPN-loop GTPase 3 isoform 1 that is encoded in the genome of human.


name: collagen alpha-3(IX) chain 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:Q14050, MOD:00037|MOD:00038|MOD:00039.


name: collagen alpha-3(IX) chain 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that includes at least one 4-hydroxy-proline. UniProtKB:Q14050, MOD:00039.


name: collagen alpha-3(IX) chain 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:Q14050, MOD:00038|MOD:00039.


name: collagen alpha-3(IX) chain 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:Q14050, MOD:00037|MOD:00039.


name: collagen alpha-3(IX) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and galactosylhydroxylysine form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 galactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:Q14050, 26-684, MOD:00038|MOD:00039(3+)|MOD:01914.


name: collagen alpha-3(IX) chain, signal peptide removed 5-hydroxy-lysine and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:Q14050, 26-684, MOD:00037|MOD:00039.


name: collagen alpha-3(IX) chain, signal peptide removed 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:Q14050, 26-684, MOD:00038|MOD:00039.


name: collagen alpha-3(IX) chain, signal peptide removed 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least one 4-hydroxy-proline. UniProtKB:Q14050, 26-684, MOD:00039.


name: collagen alpha-3(IX) chain, signal peptide removed 3-hydroxy-proline, 4-hydroxy-proline, and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least 1 3-hydroxy-proline, at least 1 glucosylgalactosylhydroxylated lysine, and at least 3 4-hydroxy-prolines. UniProtKB:Q14050, 26-684, MOD:00038|MOD:00039(3+)|MOD:00162.


name: collagen alpha-3(IX) chain, signal peptide removed 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:Q14050, 26-684, MOD:00037|MOD:00038|MOD:00039.


name: collagen alpha-3(IX) chain, signal peptide removed 4-hydroxy-proline and galactosylhydroxylysine form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least 1 galactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:Q14050, 26-684, MOD:00039(3+)|MOD:01914.


name: collagen alpha-3(IX) chain, signal peptide removed 4-hydroxy-proline and glucosylgalactosylhydroxylysine form (human)

description: A collagen alpha-3(IX) chain (human) that has had the signal peptide removed and that includes at least 1 glucosylgalactosylhydroxylated lysine and at least 3 4-hydroxy-prolines. UniProtKB:Q14050, 26-684, MOD:00039(3+)|MOD:00162.


lipid IIB

A member of the class of lipid As that is lipid IIA in which one of the free OH groups on the two N-hydroxytetradecanoyl groups is carrying a palimitoyl group.


RHYNS syndrome

description: RHYNS syndrome is characterized by the association of retinitis pigmentosa, hypopituitarism, nephronophthisis, and skeletal dysplasia.


name: microtubule-actin cross-linking factor 1 methylated 2 (human)

description: A microtubule-actin cross-linking factor 1 (human) that has been methylated on the residue at the position equivalent to Cys-3627 of the amino acid sequence represented by UniProtKB:Q9UPN3-1. Example: UniProtKB:Q9UPN3-1, Cys-3627, MOD:00660.


name: isolated focal cortical dysplasia type Ib


name: isolated focal cortical dysplasia type Ia


name: isolated focal cortical dysplasia type Ic


A secondary alcohol that is isopropanol in which one hydrogen of each methyl group is substituted by a chlorine. A liquid at room temperature (melting point -4degreeC, boiling point 174degreeC at 760 mm Hg), it is used as a solvent for hard resins and nitrocellulose.


episodic kinesigenic dyskinesia 1

description: An autosomal dominant condition caused by mutation(s) in the PRRT2 gene, encoding proline-rich transmembrane protein 2. It is characterized by dyskinesia triggered by sudden movement. It shares features with infantile convulsions and paroxysmal choreoathetosis, familial. It is an allelic disorder.


paroxysmal nonkinesigenic dyskinesia 1

description: Paroxysmal nonkinesigenic dyskinesia in which the cause of the disease is a mutation in the PNKD gene.


episodic kinesigenic dyskinesia 2

description: A dystonia characterized by autosomal dominant inheritance of recurrent brief involuntary hyperkinesias triggered by sudden movements that has material basis in variation in the chromosome region 16q13-q22.1.


paroxysmal nonkinesigenic dyskinesia 2

description: A dystonia characterized by autosomal dominant inheritance of attacks of dystonic or choreathetotic movements precipitated by stress, fatigue, coffee or alcohol intake or menstruation that has material basis in variation in the chromosome region 2q31.


name: benign paroxysmal torticollis of infancy

description: Benign paroxysmal torticollis of infancy (BPTI) is a rare functional disorder characterized by recurrent episodes of torticollic posturing of the head (inclination or tilting of the head to one side) in healthy children.


dystonia 9

description: A dystonia characterized by autosomal dominant inheritance of paroxysmal choreoathetosis and progressive spastic paraplegia, episodes are often precipitated by alcohol, fatigue, or emotional stress that has material basis in heterozygous mutation in the SLC2A1 gene on chromosome 1p34.


ECHS1-related paroxysmal dyskinesia

description: A paroxysmal dyskinesia which manifest as dystonic movements brought on by sustained exercise, that is correlated with a deficiency in the gene ECHS1 (caused by a missence mutation). Onset is typically between age two and four years.


Cervical Rhabdomyoma

description: A rare benign skeletal muscle neoplasm arising from the cervix. It is characterized by the presence of small nucleated rhabdomyoblasts within a fibrous and myxoid stroma.


Benign Cervical Soft Tissue Neoplasm

description: A rare benign mesenchymal neoplasm that arises from the cervix.


Cervical Leiomyoma

description: An uncommon benign smooth muscle neoplasm that arises from the cervix.


name: Metastatic Prostate Neuroendocrine Carcinoma

description: A neuroendocrine carcinoma that arises from the prostate gland and has spread to other anatomic sites.


name: Metastatic Prostate Small Cell Neuroendocrine Carcinoma

description: Prostate small cell neuroendocrine carcinoma that has spread to another anatomic site.


name: Advanced Prostate Small Cell Neuroendocrine Carcinoma

description: Prostate small cell neuroendocrine carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Locally Advanced Prostate Neuroendocrine Carcinoma

description: A prostate neuroendocrine carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: COP9 signalosome complex subunit 3 isoform 1 (human)

description: A COP9 signalosome complex subunit 3 isoform 1 that is encoded in the genome of human.


(S)-2-hydroxypropylphosphonic acid

2-Hydroxypropylphosphonic acid with S configuration at the chiral centre.


beta-D-glucofuranose

A D-glucofuranose that has beta- configuration at the anomeric centre.


name: pyruvate kinase PKLR isoform R-type (human)

description: A pyruvate kinase PKLR isoform R-type that is encoded in the genome of human.


NEDD4 family-interacting protein 2

A protein that is a translation product of the human NDFIP2 gene or a 1:1 ortholog thereof.


central nervous system mature teratoma

description: A teratoma composed exclusively of fully differentiated, 'adult-type' tissue elements that are sometimes arranged in a pattern resembling normal tissue relationships. Mitotic activity is low or absent. The more common ectodermal components present in a mature teratoma include skin, brain and choroid plexus. The more common mesodermal components include cartilage, bone, fat and muscle (both smooth and striated). And the most common endodermal components are cysts lined by epithelia of respiratory or enteric type and in some cases pancreatic or hepatic tissue. (Adapted from WHO)


name: adult central nervous system germ cell tumor

description: A germ cell tumor of the central nervous system occurring in adults.


name: adult central nervous system immature teratoma


brain germinoma

description: A germinoma (disease) that involves the brain.


adult central nervous system germinoma

description: A central nervous system germinoma that occurs in an adult.


name: adult central nervous system embryonal carcinoma

description: A embryonal carcinoma of the central nervous system that occurs in an adult.


polyembryoma of the ovary

description: A rare, malignant germ cell tumor arising from the ovary. It is characterized by the presence of embryoid bodies which resemble early embryos.


name: testicular yolk sac tumor, solid pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of aggregates of polygonal malignant cells with clear cytoplasm and prominent nucleoli.


childhood ovarian yolk sac tumor

description: A yolk sac tumor that arises from the ovary and occurs in children.


pineal region choriocarcinoma

description: A choriocarcinoma (disease) that involves the pineal body.


name: central nervous system immature teratoma

description: A variant of teratoma composed of incompletely differentiated components resembling fetal tissues. Even if the immature component is only a minor element of an otherwise differentiated teratoma, the tumor is still classified as immature. (Adapted from WHO)


mediastinal malignant germ cell tumor

description: An extragonadal malignant germ cell tumor that arises from the mediastinum. This category includes seminoma, embryonal carcinoma, yolk sac tumor, choriocarcinoma, mixed germ cell tumors, and immature malignant teratoma.


adult central nervous system teratoma

description: A mature or immature teratoma affecting the central nervous system and occurring in adults.


name: choriocarcinoma of the central nervous system

description: A malignant germ cell tumor of the central nervous system characterized by extra-embryonic differentiation along trophoblastic lines. The diagnosis requires the identification of cytotrophoblastic elements, as well as syncytiotrophoblastic giant cells. (WHO)


pineal region dysgerminoma

description: A dysgerminoma (disease) that involves the pineal body.


malignant cardiac germ cell tumor

description: A rare malignant germ cell tumor that arises from the pericardium.


malignant teratoma of mediastinum

description: A malignant teratoma that involves the mediastinum.


name: polyvesicular vitelline pattern testicular yolk sac tumor

description: A yolk sac tumor that arises from the testis and is characterized by the presence of collections of vesicles that are surrounded by connective tissue.


name: yolk sac tumor of central nervous system

description: A malignant germ cell tumor of the central nervous system composed of primitive-appearing epithelial cells - putatively representing yolk sac endoderm - set in a loose, variably cellular, and often conspicuously myxoid matrix, resembling extra-embryonic mesoblast. Eosinophilic hyaline globules immunoreactive for AFP are a diagnostic feature. (WHO)


name: childhood central nervous system embryonal carcinoma

description: An embryonal carcinoma that arises from the central nervous system and occurs during childhood.


immature extragonadal teratoma

description: An immature teratoma that develops as a primary tumor in an anatomic site other than the testis or ovary.


name: extragonadal non-dysgerminomatous germ cell tumor


adult yolk sac tumor

description: A yolk sac tumor that occurs in an adult.


name: reticular pattern testicular yolk sac tumor

description: A yolk sac tumor that arises from the testis and is characterized by the presence of a meshwork of small vacuolated cells resulting in a honeycomb appearance.


childhood embryonal testis carcinoma

description: An embryonal carcinoma that arises from the testis during childhood.


name: testicular yolk sac tumor, myxomatous pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of myxomatous tissue that contains collections of malignant cells with prominent nucleoli.


name: ovarian yolk sac tumor, glandular pattern

description: A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into endodermal type glandular structures.


spinal cord dermoid cyst

description: A dermoid cyst that involves the spinal cord.


malignant peritoneal germ cell tumor

description: A malignant germ cell tumor that affects the peritoneum.


name: testicular yolk sac tumor, macrocystic pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of collections of thin-walled spaces.


name: testicular yolk sac tumor, endodermal sinus pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of connective tissue stalks that contain a blood vessel and are lined by cells with clear cytoplasm and prominent nucleoli.


name: malignant pineal area germ cell neoplasm

description: A malignant germ cell tumor that arises in the pineal region. Representative examples include germinoma, immature teratoma, choriocarcinoma, embryonal carcinoma and yolk sac tumor.


polyembryoma

description: Polyembryoma is a type oftumor that develops from the cells of the gonads (testes in men or ovaries in women). Such tumors are called germ cell tumors. Polyembryomas have a distinctivelook because they are composed of many parts that are shaped like embryos, one of the earliest stages of a developing human during pregnancy. Symptoms of a polyembryoma may include an unusual bump or mass in the abdomen which can cause pain in some individuals; puberty at an unusually young age (known as precocious puberty); or irregularities in a female's menstruation. Treatment begins with surgery and may be followed by chemotherapy and/or radiation therapy. The cause of polyembryoma is not yet known.


name: ovarian yolk sac tumor, hepatoid pattern

description: A yolk sac tumor that arises from the ovary and is characterized by the presence of extensive differentiation into hepatic tissue.


extragonadal teratoma

description: Extragonadal teratoma is an extremely rare, benign or malignant germ cell tumor characterized, clinically, by a teratoma presenting in an extragonadal location (e.g. retroperitoneum, mediastinum, craniofacial or sacrococcygeal region, intraosseous, solid organs) and, histologically, by displaying well-differentiated structures, as well as immature elements. Presenting symptoms are variable depending on size and location of tumor.


name: childhood central nervous system immature teratoma

description: An immature teratoma that arises from the central nervous system and occurs during childhood.


name: central nervous system nongerminomatous germ cell tumor

description: Germ cell tumors of the central nervous system other than germinoma. This category includes teratoma, choriocarcinoma, embryonal carcinoma, and yolk sac tumor.


name: enteric pattern testicular yolk sac tumor

description: A yolk sac tumor that arises from the testis and is characterized by the presence of immature glands.


name: childhood central nervous system mature teratoma

description: A mature teratoma that arises from the central nervous system during childhood.


name: ovarian yolk sac tumor, polyvesicular vitelline pattern

description: A yolk sac tumor that arises from the ovary and is characterized by the presence of multiple dilated spaces lined by cells that resemble mesothelial cells. The dilated spaces coexist with columnar epithelial tissues.


name: childhood central nervous system germ cell tumor

description: A germ cell tumor of the central nervous system occurring in children.


childhood ovarian embryonal carcinoma

description: An embryonal carcinoma that arises from the ovary and occurs in children.


intratubular embryonal carcinoma

description: Stage 0 includes: pTis, N0, M0, S0. pTis: Intratubular germ cell neoplasia (carcinoma in situ). N0: regional lymph node metastasis. M0: No distant metastasis. S0: Marker study levels within normal limits. (AJCC 6th and 7th eds.)


pineal region mature teratoma

description: A mature teratoma that arises from the pineal region.


cardiac germ cell tumor

description: A germ cell tumor that arises within the myocardium or cardiac chambers. The reported cases have been teratomas and yolk sac tumors.


name: childhood central nervous system germinoma

description: A germinoma arising from the central nervous system during childhood.


name: adult central nervous system mixed germ cell tumor

description: A mixed germ cell tumor of central nervous system that occurs in an adult.


childhood endodermal sinus tumor

description: A yolk sac tumor that occurs during childhood.


extragonadal germ cell cancer

description: A malignant germ cell tumor that develops as a primary tumor in an anatomic site other than the testis or ovary.


name: adult central nervous system mature teratoma

description: A central nervous system mature teratoma that occurs in an adult.


uterine corpus choriocarcinoma

description: An aggressive malignant tumor arising from trophoblastic cells in the uterus during pregnancy. Approximately half of the cases develop from a complete hydatidiform mole. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.


pediatric CNS choriocarcinoma

description: A choriocarcinoma that arises from the central nervous system and occurs during childhood.


name: non-central nervous system-localized embryonal carcinoma


name: embryonal carcinoma of the central nervous system

description: A embryonal carcinoma that involves the central nervous system.


name: extragonadal nonseminomatous germ cell tumor

description: A malignant non-seminomatous germ cell tumor that develops as a primary tumor in an anatomic site other than the testis or ovary.


name: testicular yolk sac tumor, papillary pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of numerous papillary structures that are lined by cells with prominent nucleoli.


testis polyembryoma

description: A rare malignant germ cell tumor that arises from the testis and is characterized by the presence of embryoid bodies.


pineal region teratoma

description: A mature or immature teratoma that arises in the pineal region.


mixed extragonadal germ cell cancer

description: A mixed germ cell cancer that is located in areas of the body other than the ovary or testicle.


name: testicular yolk sac tumor, glandular-alveolar pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of gland-like spaces, irregular alveoli, and tubular structures.


name: childhood central nervous system mixed germ cell tumor

description: A mixed germ cell tumor that arises from the central nervous system and occurs during childhood.


name: mixed germ cell tumor of central nervous system

description: A malignant germ cell tumor of the central nervous system characterized by the presence of at least two types of germ cell neoplasia.


name: testicular yolk sac tumor, hepatoid pattern

description: A yolk sac tumor that arises from the testis and is characterized by the presence of hepatoid cells collections.


childhood brain germinoma

description: A germinoma arising from the brain during childhood.


vaginal yolk sac tumor

description: A rare yolk sac tumor that arises from the vagina. Patients present with abnormal vaginal bleeding or bloody discharge.


childhood germ cell brain tumor

description: A germ cell tumor arising from brain during childhood.


name: central nervous system endodermal sinus tumor

description: A yolk sac tumor that arises from the central nervous system and occurs during childhood.


pineal region yolk sac tumor

description: A yolk sac tumor that involves the pineal body.


name: threonine--tRNA ligase 1, cytoplasmic deaminated 1 (human)

description: A threonine--tRNA ligase 1, cytoplasmic (human) that has been deaminated on the residue at the position equivalent to Gln-111 of the amino acid sequence represented by UniProtKB:P26639-1. Example: UniProtKB:P26639-1, Gln-111, MOD:00685.


Stage IVA Vaginal Cancer AJCC v8

description: Stage IVA includes: T4, Any N, M0. T4: Tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (from AJCC 8th Ed.)


name: Childhood Anaplastic Sarcoma of the Kidney

description: An anaplastic sarcoma of the kidney that occurs during childhood.


TETRAHYDROXYSQUALENE

A  triterpenoid that is  squalene substituted by four hydroxy groups. It is isolated from Rhus taitensis and has been shown to exhibit antimycobacterial activity.


retrograde Golgi transport protein RGP1

A protein that is a translation product of the human RGP1 gene or a 1:1 ortholog thereof.


name: RAB6A-GEF complex partner protein 2 cysteinylated 2 (human)

description: A RAB6A-GEF complex partner protein 2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-51 of the amino acid sequence represented by UniProtKB:Q92546. UniProtKB:Q92546, Cys-51, MOD:00765.


name: RAB6A-GEF complex partner protein 2 methylated 1 (human)

description: A RAB6A-GEF complex partner protein 2 (human) that has been methylated on the residue at the position equivalent to Cys-51 of the amino acid sequence represented by UniProtKB:Q92546. UniProtKB:Q92546, Cys-51, MOD:00660.


name: RAB6A-GEF complex partner protein 2 cysteinylated 1 (human)

description: A RAB6A-GEF complex partner protein 2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-293 of the amino acid sequence represented by UniProtKB:Q92546. UniProtKB:Q92546, Cys-293, MOD:00765.


name: sonic hedgehog protein N-product dually lipidated 1 (human)

description: A sonic hedgehog protein N-product in human that has been further modified on the N-terminal Cys residue by palmitoylation and the C-terminal Gly residue by cholesterylation. UniProtKB:Q15465, 24-197, Cys-24, MOD:00069|Gly-197, MOD:00314.


anisotanol B

A norsesquiterpenoid with formula C14H22O3. It is isolated from Anisodus tanguticus.


name: arginine-hydroxylase NDUFAF5, mitochondrial, transit peptide removed form (human)

description: An arginine-hydroxylase NDUFAF5, mitochondrial (human) that has had the transit peptide removed. UniProtKB:Q5TEU4, 37-345.


name: protein transport protein Sec24A deaminated 2 (human)

description: A protein transport protein Sec24A (human) that has been deaminated on the residue at the position equivalent to Asn-254 of the amino acid sequence represented by UniProtKB:O95486-1. Example: UniProtKB:O95486-1, Asn-254, MOD:00684.


tumor protein p73 isoform Zeta (human)

A tumor protein p73 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O15350-6.


name: insulin-like growth factor II O-glycosylated 3 (human)

description: An insulin-like growth factor II (human) that has been O-glycosylated at the residue equivalent to Thr-96 of the amino acid sequence represented by UniProtKB:P01344-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01344-1, Thr-96, MOD:00005~GNO:G53434XO.


name: idiopathic multidrug-resistant nephrotic syndrome


name: sodium/potassium-transporting ATPase subunit beta-2 isoform 1 (human)

description: A sodium/potassium-transporting ATPase subunit beta-2 isoform 1 that is encoded in the genome of human.


name: transcription initiation protein SPT3 homolog isoform h1 (human)

description: A transcription initiation protein SPT3 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75486-1.


transcription initiation protein SPT3

A protein that is a translation product of the human SUPT3H gene or a 1:1 ortholog thereof.


name: transcription initiation protein SPT3 homolog isoform h2 (human)

description: A transcription initiation protein SPT3 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75486-4.


name: mitochondrial import inner membrane translocase subunit TIM14, initiator methionine removed form (human)

description: A mitochondrial import inner membrane translocase subunit TIM14 (human) that has had the initiator methionine removed. UniProtKB:Q96DA6, 2-116.


name: mitochondrial import inner membrane translocase subunit TIM14 isoform 1 (human)

description: A mitochondrial import inner membrane translocase subunit TIM14 isoform 1 that is encoded in the genome of human.


name: mitochondrial import inner membrane translocase subunit TIM14 isoform h2 (human)

description: A mitochondrial import inner membrane translocase subunit TIM14 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96DA6-2.


(2R,4S)-rose oxide

A rose oxide that has R configuration at position 2 and S configuration at position 4. Also known as (+)-cis-rose oxide.


name: Refractory Diffuse Intrinsic Pontine Glioma

description: Diffuse intrinsic pontine glioma that is resistant to treatment.


name: Childhood Diffuse Intrinsic Pontine Glioma

description: A diffuse intrinsic pontine glioma that occurs during childhood.


Adult Diffuse Intrinsic Pontine Glioma

description: A diffuse intrinsic pontine glioma that occurs during adulthood.


name: Recurrent Diffuse Intrinsic Pontine Glioma

description: The reemergence of diffuse intrinsic pontine glioma after a period of remission.


name: pleckstrin homology domain-containing family A member 1 isoform h2 (human)

description: A pleckstrin homology domain-containing family A member 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9HB21-2.


name: SAM pointed domain-containing Ets transcription factor isoform h2 (human)

description: A SAM pointed domain-containing Ets transcription factor (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95238-2.


name: SUN domain-containing protein 1 isoform h2 (human)

description: A SUN domain-containing protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O94901-2.


name: grainyhead-like protein 2 homolog isoform 1 (human)

description: A grainyhead-like protein 2 isoform 1 that is encoded in the genome of human.


name: grainyhead-like protein 2 homolog isoform h2 (human)

description: A grainyhead-like protein 2 homolog (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ISB3-2.


A prenylnaphthoquinone obtained by hydroxylation of one of the terminal methyl groups of menaquinone-4.


myoferlin isoform h2 (human)

A myoferlin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9NZM1-2.


name: uterine corpus atypical polypoid adenomyoma

description: An adenomyoma that arises from the uterine corpus and is characterized by the presence of marked glandular architectural complexity. It may recur following excision.


adenomyoma of uterine corpus

description: A usually polypoid, benign neoplasm that arises from the uterine corpus. It is characterized by the presence of benign epithelial glands embedded in benign fibromyomatous tissue.


name: nucleolar complex protein 2 homolog cysteinylated 2 (human)

description: A nucleolar complex protein 2 homolog (human) that has been cysteinylated on the residue at the position equivalent to Cys-263 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-263, MOD:00765.


name: nucleolar complex protein 2 homolog acetylated 1 (human)

description: A nucleolar complex protein 2 homolog (human) that has been acetylated on the residue at the position equivalent to Lys-143 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Lys-143, MOD:00723.


name: nucleolar complex protein 2 homolog methylated 1 (human)

description: A nucleolar complex protein 2 homolog (human) that has been methylated on the residue at the position equivalent to Cys-540 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-540, MOD:00660.


name: nucleolar complex protein 2 homolog cysteinylated 1 (human)

description: A nucleolar complex protein 2 homolog (human) that has been cysteinylated on the residue at the position equivalent to Cys-411 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-411, MOD:00765.


name: nucleolar complex protein 2 homolog methylated 2 (human)

description: A nucleolar complex protein 2 homolog (human) that has been methylated on the residue at the position equivalent to Cys-567 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-567, MOD:00660.


name: nucleolar complex protein 2 homolog methylated 4 (human)

description: A nucleolar complex protein 2 homolog (human) that has been methylated on the residue at the position equivalent to Cys-263 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-263, MOD:00660.


name: nucleolar complex protein 2 homolog methylated 3 (human)

description: A nucleolar complex protein 2 homolog (human) that has been methylated on the residue at the position equivalent to Cys-585 of the amino acid sequence represented by UniProtKB:Q9Y3T9. UniProtKB:Q9Y3T9, Cys-585, MOD:00660.


A 1,2-diacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as stearoyl and 8Z,11Z,14Z-icosa-8,11,14-trienoyl respectively.


name: platelet-derived growth factor receptor alpha sequence variant D846V, signal peptide removed phosphorylated 1 (human)

description: A platelet-derived growth factor receptor alpha (human) that has a Val residue at the position equivalent to Asp-846 of the amino acid sequence represented by UniProtKB:P16234-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-572, Tyr-574, Tyr-720, Tyr-731, Tyr-742, Tyr-754, Tyr-762, Tyr-768, Tyr-849, Tyr-988, and Tyr-1018. Example: UniProtKB:P16234-1, 24-1089, Tyr-572/Tyr-574/Tyr-720/Tyr-731/Tyr-742/Tyr-754/Tyr-762/Tyr-768/Tyr-849/Tyr-988/Tyr-1018, MOD:00048|Asp-846, CHEBI:30015.


name: 5'-AMP-activated protein kinase subunit gamma-1 isoform h2 (human)

description: A 5'-AMP-activated protein kinase subunit gamma-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P54619-2.


ribonuclease 3 deaminated 1 (human)

A ribonuclease 3 (human) that has been deaminated on the residue at the position equivalent to Gln-701 of the amino acid sequence represented by UniProtKB:Q9NRR4-1. Example: UniProtKB:Q9NRR4-1, Gln-701, MOD:00685.


A peptidomimetic that is an inhibitor of ferroptosis and prevents the onset of motor decline in a mouse model for Huntington's disease.


name: natural cytotoxicity triggering receptor 3 isoform h2 (human)

description: A natural cytotoxicity triggering receptor 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O14931-2.


name: insulin-like growth factor-binding protein 2

description: A protein that is a translation product of the human IGFBP2 gene or a 1:1 ortholog thereof.


name: insulin-like growth factor-binding protein 2, signal peptide removed form (human)

description: An insulin-like growth factor-binding protein 2 (human) that has had the signal peptide removed. UniProtKB:P18065, 36-325.


name: insulin-like growth factor-binding protein 2 O-glycosylated 1 (human)

description: An insulin-like growth factor-binding protein 2 (human) that has been O-glycosylated at the residue equivalent to Thr-166 of the amino acid sequence represented by UniProtKB:P18065-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P18065-1, Thr-166, MOD:00005~GNO:G43417UB.


name: period circadian protein homolog 2 methylated 3 (human)

description: A period circadian protein homolog 2 (human) that has been methylated on the residue at the position equivalent to Cys-758 of the amino acid sequence represented by UniProtKB:O15055-1. Example: UniProtKB:O15055-1, Cys-758, MOD:00660.


granzyme M isoform 1 (human)

A granzyme M isoform 1 that is encoded in the genome of human.


name: UBX domain-containing protein 6 cysteinylated 1 (human)

description: A UBX domain-containing protein 6 (human) that has been cysteinylated on the residue at the position equivalent to Cys-210 of the amino acid sequence represented by UniProtKB:Q9BZV1-1. Example: UniProtKB:Q9BZV1-1, Cys-210, MOD:00765.


name: chromatin complexes subunit BAP18 cysteinylated 1 (human)

description: A chromatin complexes subunit BAP18 (human) that has been cysteinylated on the residue at the position equivalent to Cys-66 of the amino acid sequence represented by UniProtKB:Q8IXM2-1. Example: UniProtKB:Q8IXM2-1, Cys-66, MOD:00765.


name: chromatin complexes subunit BAP18 isoform h3 (human)

description: A chromatin complexes subunit BAP18 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IXM2-3.


name: chromatin complexes subunit BAP18 methylated 1 (human)

description: A chromatin complexes subunit BAP18 (human) that has been methylated on the residue at the position equivalent to Cys-66 of the amino acid sequence represented by UniProtKB:Q8IXM2-1. Example: UniProtKB:Q8IXM2-1, Cys-66, MOD:00660.


name: chromatin complexes subunit BAP18 isoform h2 (human)

description: A chromatin complexes subunit BAP18 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IXM2-2.


name: chromatin complexes subunit BAP18 isoform h1 (human)

description: A chromatin complexes subunit BAP18 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IXM2-1.


name: reactive oxygen species modulator 1 isoform 1 (human)

description: A reactive oxygen species modulator 1 isoform 1 that is encoded in the genome of human.


name: reactive oxygen species modulator 1 methylated 1 (human)

description: A reactive oxygen species modulator 1 (human) that has been methylated on the residue at the position equivalent to Cys-42 of the amino acid sequence represented by UniProtKB:P60602-1. Example: UniProtKB:P60602-1, Cys-42, MOD:00660.


name: reactive oxygen species modulator 1 cysteinylated 1 (human)

description: A reactive oxygen species modulator 1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-27 of the amino acid sequence represented by UniProtKB:P60602-1. Example: UniProtKB:P60602-1, Cys-27, MOD:00765.


name: reactive oxygen species modulator 1 isoform h2 (human)

description: A reactive oxygen species modulator 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60602-2.


name: tight junction protein ZO-1 isoform Long (human)

description: A tight junction protein ZO-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q07157-1.


name: tight junction protein ZO-1 deaminated 1 (human)

description: A tight junction protein ZO-1 (human) that has been deaminated on the residue at the position equivalent to Asn-1605 of the amino acid sequence represented by UniProtKB:Q07157-1. Example: UniProtKB:Q07157-1, Asn-1605, MOD:00684.


name: tight junction protein ZO-1 phosphorylated 1 (human)

description: A tight junction protein ZO-1 (human) that has been phosphorylated on the residue at the position equivalent to Thr-1484 of the amino acid sequence represented by UniProtKB:Q07157-1. Example: UniProtKB:Q07157-1, Thr-1484, MOD:00047.


name: tight junction protein ZO-1 isoform Short (human)

description: A tight junction protein ZO-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q07157-2.


name: tyrosine-protein phosphatase non-receptor type 2 isoform h1 (human)

description: A tyrosine-protein phosphatase non-receptor type 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P17706-1.


kelch-like protein 38 isoform 1 (human)

A kelch-like protein 38 isoform 1 that is encoded in the genome of human.


kelch-like protein 38

A protein that is a translation product of the human KLHL38 gene or a 1:1 ortholog thereof.


kappa-casein O-glycosylated 28 (human)

A kappa-casein (human) that has been O-glycosylated at the residue equivalent to Thr-143 of the amino acid sequence represented by UniProtKB:P07498-1, in which the glycan structure is represented by GlyTouCan:G41424HD. Example: UniProtKB:P07498-1, Thr-143, MOD:00005~GNO:G41424HD.


name: ferritin light chain deaminated 3 (human)

description: A ferritin light chain (human) that has been deaminated on the residue at the position equivalent to Asn-22 of the amino acid sequence represented by UniProtKB:P02792. UniProtKB:P02792, Asn-22, MOD:00684.


name: globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform h2 (human)

description: A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N5D6-2.


name: globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform h3 (human)

description: A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8N5D6-3.


name: globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform 1 (human)

description: A globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform 1 that is encoded in the genome of human.


name: mast/stem cell growth factor receptor Kit sequence variant D419A, signal peptide removed phosphorylated 1 (human)

description: A mast/stem cell growth factor receptor Kit (human) that has an Ala residue at the position equivalent to Asp-419 of the amino acid sequence represented by UniProtKB:P10721-1, that has had the signal peptide removed, and that has been phosphorylated on the residues at the positions equivalent to Tyr-568, Tyr-570, Tyr-703, Tyr-721, Tyr-730, Tyr-823, and Tyr-936. Example: UniProtKB:P10721-1, 26-976, Asp-419, CHEBI:46217|Tyr-568/Tyr-570/Tyr-703/Tyr-721/Tyr-730/Tyr-823/Tyr-936, MOD:00048.


primary ciliary dyskinesia 16

description: Any primary ciliary dyskinesia in which the cause of the disease is a mutation in the DNAL1 gene.


name: ferric-chelate reductase 1 O-glycosylated 1 (human)

description: A ferric-chelate reductase 1 (human) that has been O-glycosylated at the residue equivalent to Thr-182 of the amino acid sequence represented by UniProtKB:Q6ZNA5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q6ZNA5-1, Thr-182, MOD:00005~GNO:G43417UB.


name: BMP receptor type-2 sequence variant C118W (human)

description: A bone morphogenetic protein receptor type-2 (human) that has a Trp residue at the position equivalent to Cys-118 of the amino acid sequence represented by UniProtKB:Q13873-1. Example: UniProtKB:Q13873-1, Cys-118, CHEBI:29954.


An L-alpha-amino acid that is L-valine in which all five carbons are (13)C isotopes while the nitrogen is the (15)N isotope.


name: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 isoform h2 (human)

description: An NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O96000-2.


Borderline Breast Phyllodes Tumor

description: A phyllodes tumor of the breast characterized by the presence of intermediate features and a stroma which usually resembles low grade fibrosarcoma.


A triglyceride in which the 1- and 3-acyl groups are palmitoyl while that at position 2 is oleoyl.


triacylglycerol 50:1

A triglyceride in which the three acyl groups contain a total of 50 carbons and 1 double bond.


A triacylglycerol 50:1 in which the acyl groups at positions 1, 2 and 3 are specified as oleoyl, isoheptadecanoyl and pentadecanoyl respectively.  It is a metabolite of the nematode Caenorhabditis elegans.


name: Endometrioid Tumor, Variant with Squamous Differentiation

description: An endometrioid tumor exhibiting squamous differentiation.


name: Endometrioid Adenocarcinoma, Variant with Squamous Differentiation

description: An endometrioid adenocarcinoma exhibiting squamous differentiation.


albumin methylated 6 (human)

An albumin (human) that has been methylated on the residue at the position equivalent to Cys-485 of the amino acid sequence represented by UniProtKB:P02768-1. Example: UniProtKB:P02768-1, Cys-485, MOD:00660.


name: poly(A) RNA polymerase GLD2 isoform 1 (human)

description: A poly(A) RNA polymerase GLD2 isoform 1 that is encoded in the genome of human.


name: 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 isoform h5 (human)

description: A 2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BZG8-5.


name: serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform deaminated 1 (human)

description: A serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (human) that has been deaminated on the residue at the position equivalent to Gln-72 of the amino acid sequence represented by UniProtKB:P30153. UniProtKB:P30153, Gln-72, MOD:00685.


name: aldo-keto reductase family 1 member C3 cysteinylated 1 (human)

description: An aldo-keto reductase family 1 member C3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-145 of the amino acid sequence represented by UniProtKB:P42330-1. Example: UniProtKB:P42330-1, Cys-145, MOD:00765.


aldo-keto reductase family 1 member C3

A protein that is a translation product of the human AKR1C3 gene or a 1:1 ortholog thereof.


name: aldo-keto reductase family 1 member C3 isoform h2 (human)

description: An aldo-keto reductase family 1 member C3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42330-2.


name: aldo-keto reductase family 1 member C3 isoform h1 (human)

description: An aldo-keto reductase family 1 member C3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P42330-1.


COVID-19-Associated Ageusia

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: Ageusia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).


protein dopey-2 isoform h1 (human)

A protein dopey-2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y3R5-1.


Benign Cardiac Germ Cell Tumor

description: A germ cell tumor that arises within the myocardium or cardiac chambers. There is no evidence of atypia or metastases.


name: ETS domain-containing protein Elk-1 isoform h1 (human)

description: An ETS domain-containing protein Elk-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P19419-1.


name: glycerophosphodiester phosphodiesterase domain-containing protein 5 isoform h5 (human)

description: A glycerophosphodiester phosphodiesterase domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WTR4-5.


name: glycerophosphodiester phosphodiesterase domain-containing protein 5 isoform h2 (human)

description: A glycerophosphodiester phosphodiesterase domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WTR4-2.


name: glycerophosphodiester phosphodiesterase domain-containing protein 5 isoform h1 (human)

description: A glycerophosphodiester phosphodiesterase domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WTR4-1.


name: glycerophosphodiester phosphodiesterase domain-containing protein 5 isoform h3 (human)

description: A glycerophosphodiester phosphodiesterase domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WTR4-3.


name: glycerophosphodiester phosphodiesterase domain-containing protein 5 isoform h4 (human)

description: A glycerophosphodiester phosphodiesterase domain-containing protein 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8WTR4-4.


Malignant Pancreatic Insulinoma

description: An insulin-producing neuroendocrine tumor arising from the beta cells of the pancreas.  Patients exhibit symptoms related to hypoglycemia due to inappropriate secretion of insulin. It displays vascular invasion and metastasizes to other anatomic sites.


protrudin isoform h1 (human)

A protrudin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5T4F4-1.


An aldehyde that is thiophene substituted by a formyl group at position 2.


name: mothers against decapentaplegic homolog 4 isoform 1 (human)

description: A smad4 isoform 1 that is encoded in the genome of human.


name: mothers against decapentaplegic homolog 4 isoform 1 monoubiquitinated 1 (human)

description: A smad4 isoform 1 monoubiquitinated 1 in human. UniProtKB:Q13485-1, Lys-507, MOD:01148.


name: mothers against decapentaplegic homolog 4 isoform 1 phosphorylated 1 (human)

description: A smad4 isoform 1 phosphorylated 1 in human. UniProtKB:Q13485-1, Thr-277, MOD:00047.


name: mothers against decapentaplegic homolog 4 isoform 1 monoubiquitinated 2 (human)

description: A smad4 isoform 1 monoubiquitinated 2 in human. UniProtKB:Q13485-1, Lys-519, MOD:01148.


name: proton-coupled zinc antiporter SLC30A8 isoform h1 (human)

description: A proton-coupled zinc antiporter SLC30A8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IWU4-1.


name: E3 SUMO-protein ligase PIAS1 cysteinylated 1 (human)

description: An E3 SUMO-protein ligase PIAS1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-168 of the amino acid sequence represented by UniProtKB:O75925-1. Example: UniProtKB:O75925-1, Cys-168, MOD:00765.


name: E3 SUMO-protein ligase PIAS3 isoform 1 (human)

description: An E3 SUMO-protein ligase PIAS3 isoform 1 that is encoded in the genome of human.


name: E3 SUMO-protein ligase PIAS4, initiator methionine removed sumoylated 1 (human)

description: An E3 SUMO-protein ligase PIAS4 (human) that has had the initiator methionine removed and that has been sumoylated on the residue at the position equivalent to Lys-35 of the amino acid sequence represented by UniProtKB:Q8N2W9. UniProtKB:Q8N2W9, 2-510, Lys-35, MOD:01149.


name: E3 SUMO-protein ligase PIAS1 isoform h2 (human)

description: An E3 SUMO-protein ligase PIAS1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75925-2.


name: E3 SUMO-protein ligase PIAS2 isoform h3 (human)

description: An E3 SUMO-protein ligase PIAS2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75928-3.


E3 SUMO-protein ligase PIAS1

An E3 SUMO-protein ligase PIAS that is a translation product of the human PIAS1 gene or a 1:1 ortholog thereof.


name: E3 SUMO-protein ligase PIAS2 isoform hPIAS2-alpha (human)

description: An E3 SUMO-protein ligase PIAS2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75928-2.


name: E3 SUMO-protein ligase PIAS1 isoform h3 (human)

description: An E3 SUMO-protein ligase PIAS1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75925-3.


E3 SUMO-protein ligase PIAS2

An E3 SUMO-protein ligase PIAS that is a translation product of the human PIAS2 gene or a 1:1 ortholog thereof.


name: E3 SUMO-protein ligase PIAS1 phosphorylated 1 (human)

description: An E3 SUMO-protein ligase PIAS1 (human) that has been phosphorylated on the residue at the position equivalent to Ser-522 of the amino acid sequence represented by UniProtKB:O75925-1. Example: UniProtKB:O75925-1, Ser-522, MOD:00046.


name: E3 SUMO-protein ligase PIAS2 cysteinylated 1 (human)

description: An E3 SUMO-protein ligase PIAS2 (human) that has been cysteinylated on the residue at the position equivalent to Cys-192 of the amino acid sequence represented by UniProtKB:O75928-1. Example: UniProtKB:O75928-1, Cys-192, MOD:00765.


name: E3 SUMO-protein ligase PIAS3 glutathionylated 1 (human)

description: An E3 SUMO-protein ligase PIAS3 (human) that has been glutathionylated on the residue at the position equivalent to Cys-418 of the amino acid sequence represented by UniProtKB:Q9Y6X2. UniProtKB:Q9Y6X2, Cys-418, MOD:00234.


name: E3 SUMO-protein ligase PIAS4, initiator methionine removed form (human)

description: An E3 SUMO-protein ligase PIAS4 (human) that has had the initiator methionine removed. UniProtKB:Q8N2W9, 2-510.


name: E3 SUMO-protein ligase PIAS2 isoform hPIAS2-beta (human)

description: An E3 SUMO-protein ligase PIAS2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75928-1.


name: E3 SUMO-protein ligase PIAS1 isoform 1 (human)

description: An E3 SUMO-protein ligase PIAS1 isoform 1 that is encoded in the genome of human.


E3 SUMO-protein ligase PIAS3

An E3 SUMO-protein ligase PIAS that is a translation product of the human PIAS3 gene or a 1:1 ortholog thereof.


E3 SUMO-protein ligase PIAS4

An E3 SUMO-protein ligase PIAS that is a translation product of the human PIAS4 gene or a 1:1 ortholog thereof.


name: E3 SUMO-protein ligase PIAS3 cysteinylated 1 (human)

description: An E3 SUMO-protein ligase PIAS3 (human) that has been cysteinylated on the residue at the position equivalent to Cys-418 of the amino acid sequence represented by UniProtKB:Q9Y6X2. UniProtKB:Q9Y6X2, Cys-418, MOD:00765.


name: E3 SUMO-protein ligase PIAS3 methylated 1 (human)

description: An E3 SUMO-protein ligase PIAS3 (human) that has been methylated on the residue at the position equivalent to Cys-418 of the amino acid sequence represented by UniProtKB:Q9Y6X2. UniProtKB:Q9Y6X2, Cys-418, MOD:00660.


name: E3 SUMO-protein ligase PIAS1 methylated 1 (human)

description: An E3 SUMO-protein ligase PIAS1 (human) that has been methylated on the residue at the position equivalent to Cys-228 of the amino acid sequence represented by UniProtKB:O75925-1. Example: UniProtKB:O75925-1, Cys-228, MOD:00660.


name: transcription factor MafK isoform 1 (human)

description: A transcription factor MafK isoform 1 that is encoded in the genome of human.


name: Toll-like receptor 7 deaminated 14 (human)

description: A Toll-like receptor 7 (human) that has been deaminated on the residue at the position equivalent to Asn-733 of the amino acid sequence represented by UniProtKB:Q9NYK1. UniProtKB:Q9NYK1, Asn-733, MOD:00684.


name: ubiquitin carboxyl-terminal hydrolase 37 isoform h1 (human)

description: A ubiquitin carboxyl-terminal hydrolase 37 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86T82-1.


name: ubiquitin carboxyl-terminal hydrolase 37 isoform h2 (human)

description: A ubiquitin carboxyl-terminal hydrolase 37 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q86T82-2.


name: ubiquitin carboxyl-terminal hydrolase 37 methylated 1 (human)

description: A ubiquitin carboxyl-terminal hydrolase 37 (human) that has been methylated on the residue at the position equivalent to Cys-473 of the amino acid sequence represented by UniProtKB:Q86T82-1. Example: UniProtKB:Q86T82-1, Cys-473, MOD:00660.


TERT Deficiency

description: A condition of decreased or absent presence of telomerase reverse transcriptase. Deficiency of this protein is associated with autosomal dominant dyskeratosis congenital 2, autosomal recessive dyskeratosis congenita 4, telomere-related pulmonary fibrosis, and bone marrow failure 1.


Ovarian Dermoid Cyst with Melanoma

description: A secondary melanoma that has developed in an ovarian dermoid cyst.


gonadal teratoma

description: A teratoma that arises from the testis or ovary.


mature ovarian teratoma

description: An ovarian teratoma which may be cystic, composed entirely of well differentiated, adult-type tissues, without evidence of fetal-type tissues.


Grade 1 Ovarian Teratoma

description: A teratoma that arises from the ovary. It contains mature tissue elements and a limited amount of immature tissue elements.


Childhood Testicular Immature Teratoma

description: An immature teratoma that arises from the testis and occurs in children.


name: Ovarian Dermoid Cyst with Adenocarcinoma

description: A secondary adenocarcinoma that has developed in an ovarian dermoid cyst.


Stage I Ovarian Teratoma AJCC v6 and v7

description: Stage I includes: (T1, N0, M0). T1: Tumor limited to ovaries (one or both).  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)


name: Ovarian Dermoid Cyst with Leiomyosarcoma

description: A secondary leiomyosarcoma that has developed in an ovarian dermoid cyst.


childhood immature teratoma of ovary

description: An immature teratoma that arises from the ovary and occurs in children.


name: Stage IV Ovarian Teratoma AJCC v6 and v7

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis (excludes peritoneal metastasis). (AJCC 6th and 7th eds.)


name: Testicular Teratoma with Somatic-Type Malignancy

description: A testicular teratoma associated with a distinct secondary component that resembles a somatic-type malignant neoplasm (e.g., carcinoma or sarcoma).


struma ovarii

description: An ovarian mature teratoma characterized by the presence of aberrant thyroid tissue. The aberrant thyroid tissue shows morphologic changes identical to thyroid adenoma or carcinoma. Patients may present with abdominal mass and unusual symptoms due to thyrotoxicosis, or Meigs syndrome (ascites and pleural effusion).


name: Ovarian Dermoid Cyst with Somatic-Type Malignancy

description: An ovarian dermoid cyst associated with a distinct secondary component that resembles a somatic-type malignant neoplasm (e.g., carcinoma or sarcoma).


name: Ovarian Dermoid Cyst with Secondary Carcinoma

description: A secondary carcinoma that has developed in an ovarian dermoid cyst.  In the majority of cases, the secondary carcinoma is a squamous cell carcinoma.


name: Ovarian Dermoid Cyst with Secondary Sebaceous Tumor

description: A secondary sebaceous adenoma or sebaceous carcinoma that has developed in an ovarian dermoid cyst.


Ovarian Teratoma with Carcinoid Tumor

description: An ovarian teratoma characterized by the presence of a neoplastic neuroendocrine component consistent with carcinoid tumor.


Strumal carcinoid

description: An ovarian neoplasm characterized by the presence of aberrant thyroid tissue and a carcinoid tumor. A minority of patients develop symptoms of functioning thyroid tissue. The neuroendocrine carcinoid cells infiltrate the aberrant thyroid tissue and progressively replace the follicular lining cells.


name: Stage I Testicular Immature Teratoma AJCC v6 and v7

description: Stage I includes: pT1-4, N0, M0, SX.  pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis.  pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis.  pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion.  pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  SX: Marker studies not available or not performed. (AJCC 6th and 7th eds.)


name: Ovarian Dermoid Cyst with Secondary Tumor

description: An adult-type tumor that has derived from an ovarian dermoid cyst.  Representative examples include dermoid cyst with secondary carcinoma, dermoid cyst with secondary sarcoma, and dermoid cyst with pituitary-type tumor.


name: Ovarian Dermoid Cyst with Secondary Sarcoma

description: A secondary sarcoma that has developed in an ovarian dermoid cyst.  Representative examples of secondary sarcomas include leiomyosarcoma, fibrosarcoma, and angiosarcoma.


ovarian biphasic or triphasic teratoma

description: A germ cell tumor that arises from the ovary and is composed of tissues that originate from two or three of the following germ layers, endoderm, ectoderm, or mesoderm.


name: Stage III Testicular Immature Teratoma AJCC v6 and v7

description: Stage III includes: Any pT/TX, Any N, M1, SX.  M1: Distant metastasis. SX: Marker studies not available or not performed.  (AJCC 6th and 7th eds.)


Childhood Testicular Teratoma

description: A teratoma that arises from the testis during childhood.


ovarian monodermal teratoma

description: A teratoma that arises from the ovary and is characterized by the presence of tissues derived exclusively from one embryonic germ cell layer.


Testicular Teratoma, Prepubertal-Type

description: A testicular teratoma that is not associated with germ cell neoplasia in situ or chromosome 12p amplification.


name: Stage III Ovarian Teratoma AJCC v6 and v7

description: Stage III includes: T3, N0, M0. T3: Tumor involves one or both both ovaries with microscopically confirmed peritoneal metastasis outside pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)


name: Ovarian Dermoid Cyst with Corticotropin Secreting Adenoma

description: A corticotropin secreting adenoma that has developed in an ovarian dermoid cyst.  It may present with Cushing syndrome.  The clinical course is benign.


Malignant Ovarian Teratoma

description: A teratoma that arises from the ovary. It is composed exclusively of immature tissue elements.


name: Ovarian Dermoid Cyst with Secondary Pituitary-Type Tumor

description: A secondary corticotropin secreting adenoma or prolactin secreting adenoma that has developed in an ovarian dermoid cyst.  The clinical course is benign.


Testicular Dermoid Cyst

description: A mature teratoma that arises from the testis and is characterized by the presence of one or more cysts.  The cysts are lined by squamous epithelium and contain skin appendages.  Other teratomatous components may or may not be present.


Monodermal Testicular Teratoma

description: A teratoma that arises from the testis.  It is composed exclusively of one of the following tissue types: endoderm, ectoderm, or mesoderm.


ovarian cystic teratoma

description: A teratoma that arises from the ovary and is characterized by the presence of cystic structures. Representative example is the dermoid cyst.


name: Ovarian Dermoid Cyst with Squamous Cell Carcinoma

description: A secondary squamous cell carcinoma that has developed in an ovarian dermoid cyst.


childhood teratoma of the ovary

description: A mature or immature teratoma that arises from the ovary and occurs in children.


name: Ovarian Dermoid Cyst with Sebaceous Carcinoma

description: A secondary sebaceous carcinoma that has developed in an ovarian dermoid cyst.


name: Stage II Testicular Immature Teratoma AJCC v6 and v7

description: Stage II includes: Any pT/TX, N1-3, M0, SX.  pTX: Primary tumor cannot be assessed.  N1: Metastasis with a lymph node mass 2 cm or less in greatest dimension; or multiple lymph nodes, none more than 2cm in greatest dimension.  N2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, any one mass greater than 2 cm but not more than 5 cm in greatest dimension.  N3: Metastasis with a lymph node mass more than 5 cm in greatest dimension. M0: No distant metastasis. SX: Marker studies not available or not performed.  (AJCC 6th and 7th eds.)


ovarian fetiform teratoma

description: A rare type of teratoma that arises from the ovary and resembles a malformed fetus.


name: Ovarian Dermoid Cyst with Melanocytic Nevus

description: A secondary melanocytic nevus that has developed in an ovarian dermoid cyst.


name: Ovarian Dermoid Cyst with Sebaceous Adenoma

description: A secondary sebaceous adenoma that has developed in an ovarian dermoid cyst.


childhood mature teratoma of the ovary

description: A mature teratoma that arises from the ovary and occurs in children.


name: Ovarian Dermoid Cyst with Secondary Melanocytic Lesion

description: A secondary melanoma or melanocytic nevus that has developed in an ovarian dermoid cyst.


Testicular Mature Teratoma

description: A teratoma that arises from the testis and is composed of well differentiated, adult-type tissues.


name: Stage II Ovarian Teratoma AJCC v6 and v7

description: Stage II includes: T2, N0, M0. T2: Tumor involves one or both ovaries with pelvic extension and/or implants. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 6th and 7th eds.)


name: Ovarian Dermoid Cyst with Prolactin Secreting Adenoma

description: A prolactin secreting adenoma that has developed in an ovarian dermoid cyst.  It may present with hyperprolactinemia and amenorrhea.  The clinical course is benign.


malignant teratoma of testis

description: A malignant teratoma that involves the testis.


Childhood Testicular Mature Teratoma

description: A mature teratoma that arises from the testis and occurs in children.


Testicular Teratoma, Postpubertal-Type

description: A testicular teratoma associated with germ cell neoplasia in situ and chromosome 12p amplification.


name: ovarian monodermal and highly specialized teratoma

description: A teratoma of the ovary composed exclusively or predominantly of a single type of tissue derived from the ectoderm or endoderm. A representative example is struma ovarii which is a teratoma composed exclusively or predominantly of thyroid tissue.


Ovarian Dermoid Cyst with Angiosarcoma

description: A secondary angiosarcoma that has developed in an ovarian dermoid cyst.


name: T-cell acute lymphocytic leukemia protein 1

description: A protein that is a translation product of the human TAL1 gene or a 1:1 ortholog thereof.


name: T-cell acute lymphocytic leukemia protein 1 isoform hPP42-TAL1 (human)

description: A T-cell acute lymphocytic leukemia protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P17542-1.


name: T-cell acute lymphocytic leukemia protein 1 isoform hPP39-TAL1 (human)

description: A T-cell acute lymphocytic leukemia protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P17542-2.


name: T-cell acute lymphocytic leukemia protein 1 phosphorylated 1 (human)

description: A T-cell acute lymphocytic leukemia protein 1 (human) that has been phosphorylated on the residue at the position equivalent to Thr-90 of the amino acid sequence represented by UniProtKB:P17542-1. Example: UniProtKB:P17542-1, Thr-90, MOD:00047.


name: T-cell acute lymphocytic leukemia protein 1 isoform hPP22-TAL1 (human)

description: A T-cell acute lymphocytic leukemia protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P17542-3.


guignardone N

A meroterpenoid found in Guignardia and Fusarium species and shown to exhibit inhibitory activity against Candida albicans growth.